Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
| Main Authors: | , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
American Heart Association
2022
|
| Main Authors: | , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
American Heart Association
2022
|